REFERENCES:
1. Lim HS. The Effect of Impella CP on Cardiopulmonary Physiology During
Venoarterial Extracorporeal Membrane Oxygenation Support. Artif Organs
2017;41(12):1109-12.
2. Sabra MJ, Andrews WG, Crandall ML, et al. The postoperative use of
Impella as a ventricular assist device in high-risk patients undergoing
coronary artery bypass surgery: A case series and comparison. J Card
Surg 2020;35(1):113-117.
3. Schibilsky D, Lausberg H, Haller C, et al. Impella 5.0 Support in
INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary
Artery Access. Artif Organs 2015;39(8):660-3.
4. Grajeda Silvestri ER, Pino JE, Donath E, et al. Impella to unload the
left ventricle in patients undergoing venoarterial extracorporeal
membrane oxygenation for cardiogenic shock: A systematic review and
meta-analysis. J Card Surg 2020;35(6):1237-1242.
5. Madjarov JM, Katz MG, Fazal S, et al. Mechanical circulatory support
with extracorporeal membrane oxygenation and Impella 5.5 in patients
with a postinfarction VSD: Combined or separate assist strategy? J Card
Surg 2020;Nov 22. doi: 10.1111/jocs.15204.
6. Yin MY, Wever-Pinzon O, Mehra MR, et al. Post-transplant outcome in
patients bridged to transplant with temporary mechanical circulatory
support devices. J Heart Lung Transplant 2019;38(8):858-869.
7. Sef D, Mohite P, De Robertis F, et al. Bridge to heart
transplantation using the Levitronix CentriMag short-term ventricular
assist device. Artif Organs 2020 Sep;44(9):1006-1008.
8. Wong ASK, Sin SWC. Short-term mechanical circulatory support
(intra-aortic balloon pump, Impella, extracorporeal membrane
oxygenation, TandemHeart): a review. Ann Transl Med 2020;8(13):829.
9. Dixon SR, Henriques Jose PS, Mauri L, et al. A prospective
feasibility trial investigating the use of the Impella 2.5 system in
patients undergoing high-risk percutaneous coronary intervention (The
PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv
2009;2(2):91-6.
10. Alushi B, Douedari A, Froehlig G, et al. Impella versus IABP in
acute myocardial infarction complicated by cardiogenic shock. Open Heart
2019;6(1):e000987.
11. Ouweneel DM, Eriksen E, Seyfarth M, Henriques Jose PS. Percutaneous
Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump for
Treating Cardiogenic Shock: Meta-Analysis. J Am Coll Cardiol
2017;69(3):358-360.
12. Barge-Caballero E, Almenar-Bonet L, Gonzalez-Vilchez F, et al.
Clinical outcomes of temporary mechanical circulatory support as a
direct bridge to heart transplantation: a nationwide Spanish registry.
Eur J Heart Fail 2018;20(1):178-186.
13. Iannaccone M, Albani S, Giannini F, et al. Short term outcomes of
Impella in cardiogenic shock: A review and meta-analysis of
observational studies. Int J Cardiol, 2020. Sep 22;pii:
S0167-5273(20)33825-0. doi: 10.1016/j.ijcard.2020.09.044.
14. Chandola R, Cusimano R, Osten M, Horlick E. Severe aortic
insufficiency secondary to 5L Impella device placement. J Card Surg
2012;27(3):400-2.
15. Hong E, Naseem T. Color Doppler Artifact Masking Iatrogenic Aortic
Valve Injury Related to an Impella Device. J Cardiothorac Vasc Anesth
2019;33(6):1584-1587.
16. Vila P, de Vere F, Simon A, Walker C. Severe aortic valve
regurgitation requiring mechanical aortic valve replacement following
Impella device implantation. Perfusion 2020; Jul 15:267659120941339.
doi: 10.1177/0267659120941339. Epub ahead of print.
17. Sharma S, Briasoulis A, Afonso L. Persistent aortic insufficiency
secondary to Impella device implantation. Int J Cardiol
2014;176(1):e9-10.
18. Butala B, Yu R, Schorr R, Gologorsky E. Periprocedural Dynamics of
Aortic Regurgitation in Patients Supported With an Impella Left
Ventricular Assist Device. J Cardiothorac Vasc Anesth
2020;34(3):659-662.
19. Bhatia N, Richardson TD, Coffin ST, Keebler ME. Acute Mitral
Regurgitation After Removal of an Impella Device. Am J Cardiol
2017;119(8):1290-1291.
20. Khalid N, Shlofmitz E, Case BC, Waksman R. Chordae Tendineae Rupture
and Iatrogenic Severe Mitral Regurgitation Related to Impella.
EuroIntervention 2020; Feb 18;EIJ-D-19-00942. doi:
10.4244/EIJ-D-19-00942. Epub ahead of print.
21. Pivato CA, Ferrante G, Briani M, Sanz Sanchez J, Reimers B, Pagnotta
P. Mitraclip treatment for severe mitral regurgitation due to chordae
rupture following Impella CP support in a patient with severe aortic
stenosis. Cardiovasc Revasc Med 2020; Aug 15:S1553-8389(20)30496-6. doi:
10.1016/j.carrev.2020.08.027. Epub ahead of print.
22. Elhussein TA, Hutchison SJ. Acute mitral regurgitation: unforeseen
new complication of the Impella LP 5.0 ventricular assist device and
review of literature. Heart Lung Circ 2014;23(3):e100-4.
23. O’Neill WW, Schreiber T, Wohns DH, et al. The current use of Impella
2.5 in acute myocardial infarction complicated by cardiogenic shock:
results from the USpella Registry. J Interv Cardiol 2014;27(1):1-11.
24. Toggweiler S, Jamshidi P, Erne P. Functional mitral stenosis: a rare
complication of the Impella assist device. Eur J Echocardiogr
2008;9(3):412-3.